Composite Patient Reports: A Laboratory Informatics Perspective and Pilot Project for Personalized Medicine and Translational Research by Gundlapalli, Adi V. et al.
Composite Patient Reports: A Laboratory Informatics Perspective and Pilot Project for  
Personalized Medicine and Translational Research 
 
Adi V. Gundlapalli, MD, PhD,MS
1,2,3,4, Julio C. Delgado, MD, MS
2,4, 
Brian R. Jackson, MD, MS
2,3,4, Guido J. Tricot, MD, PhD
1, Harry R. Hill, MD
1,2,4 
1Departments of Internal Medicine, 
2Pathology and 
3Biomedical Informatics, 
University of Utah School of Medicine, 
4ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, Utah 
 
Clinical laboratories are a strong and integral 
partner in personalized health care.  Laboratory 
information systems hold a vast amount of data 
representing  human  phenotypes,  genotypes, 
biomarkers, progression of disease and response 
to therapy.  These structured and unstructured 
free text data are critical for patient care and a 
resource  for  personalized  medicine  and 
translational  research.    Laboratory  data  are 
integrated into many electronic medical records 
that provide “summary reports” and “trending” 
to visualize longitudinal patient data.  However, 
these  generic  reports  are  not  sufficient  to 
manage complex sub-specialty patients.  There is 
an  urgent  need  for  end-user  driven  composite 
reports  for  the  care  of  such  patients.  Using 
multiple  myeloma  as  a  model,  this  pilot  was 
performed  to  assess  the  needs  of  stakeholders 
and create a customized report. This laboratory 
informatics solution is delivered at the point of 
care  through  the  hospital  EMR.    Future  work 
will  involve  further  integration  with  hospital 
systems to promote clinical decision support and 
translational research. 
Introduction 
  The goal of personalized health care is to make 
patient  data  available  at  the  right  time,  in  the 
right format and within the normal workflow [1].  
The objective is to support providers, decrease 
time  spent  in  gathering  data  and  improve  the 
quality  of  care  for  patients.    While  this  is 
important for all patients, it is especially critical 
for sub-specialty patients with complex medical 
conditions and longitudinal data. The availability 
and easy access to these data are important for 
the sub-specialty provider for routine patient care 
and  for  others  called  upon  to  provide  cross-
coverage or emergency care [2]. 
 
  Clinical  laboratories  generate  and  archive 
patient  data  in  laboratory  information 
management  systems  (LIMS).    These  data 
include biochemical manifestations of organisms  
(phenotypes), genotypes and biomarkers that are 
essential  to  the  diagnosis,  determination  of 
progression and response to therapy of a disease.  
These data form the foundation for clinical care, 
personalized medicine and translational research 
from an informatics standpoint of data capture, 
organization,  integrity  and  flow  [3].  Where 
available,  laboratory  data  are  integrated  into 
electronic  medical  records  and  are  accessed 
routinely by medical personnel.  Longitudinal or 
serial  laboratory  tests  are  usually  viewed 
graphically  or  in  tabular  form  via  summary 
reports or trends [4].  These reports are useful for 
visualizing  structured  data  in  the  form  of 
numeric values with flags for abnormal values.  
They are less optimal for data that are available 
only in unstructured free text in written reports 
or pictorially represented in graphs and gels from 
molecular  genetics,  anatomic  pathology  and 
other  specialized  testing  such  as  protein 
immunology.   
 
  The medical care of patients in fields such as 
transplant  medicine,  cancer,  HIV/AIDS,  etc. 
generates  large  volumes  of  data  including 
critically  important  serial  laboratory  data. 
Currently,  there  are  no  readily  available 
composite  laboratory  data  reports  that 
incorporate  both  structured  and  unstructured 
elements  for  use  in  the  care  of  such  complex 
medical patients.  Prior informatics  work [5-9] 
and our clinical partners have indicated that such 
automated reports would be useful in improving 
care  while  reducing  time  in  gathering  and 
collating these results manually. 
 
  Using multiple myeloma as a model disease, 
this pilot project addresses the hypotheses that: 
(1)  Clinical  providers  perceive  composite 
laboratory reports to be important for the care of 
complex  patients  and  (2)  Such  reports  can  be 
generated using laboratory informatics methods. 
Multiple  myeloma  (MM)  is  the  second  most 
common cancer of the blood in which antibody 
producing plasma cells become malignant [10]. 
Routine clinical care of these patients involves a 
time-consuming data gathering phase where the 
results  of  a  battery  of  immunology  tests, 
biomarkers and more recently, gene expression 
39data  are  accessed  and  collated  to  assess 
progression of disease and response to therapy 
[11-13].  
 
Setting 
  This  pilot  project  was  carried  out  at  the 
University  of  Utah  School  of  Medicine  and 
ARUP  Laboratories  (ARUP).    The  University 
Myeloma Program consists of a dedicated staff 
of  physicians,  mid-level  practitioners, 
pharmacists, nurses and other support personnel.  
ARUP  is  a  national  clinical  and  anatomic 
pathology reference laboratory that is owned by 
the  University  and  performs  all  the  testing  for 
MM  patients  from  the  University.    ARUP 
performs nearly 1500 protein immunology tests 
per week from the University and other clients. 
The  LIMS  at  ARUP  consists  of  a  commercial 
system with a direct interface to the University 
of  Utah  electronic  medical  record  (EMR).  
Results  of  tests  are  available  at  the  University 
immediately upon finalizing and approval in the 
ARUP system. 
Methods 
  A  semi-structured  survey  and  interview  was 
conducted  among  the  clinical  staff  of  the 
University Myeloma Program, that included: (1) 
Questions regarding their role in the team, years 
of experience and hospital EMR access patterns; 
(2) Their time spent in gathering and correlating 
laboratory  data  for  patients  with  special 
emphasis  on  protein  immunology  tests  and  (3) 
Their opinions on a composite report and choice 
of protein immunology tests if a such a report 
were to be available for myeloma patients. The 
existing flow of data for laboratory tests between 
the University Hospital and ARUP was mapped. 
A rules-based inference engine was developed to 
extract specific test results identified by the end-
users. These data provided the design rationale 
of a sample composite report for MM patients. 
 
Results 
End-user  survey:  All  ten  members  of  the 
Myeloma program that routinely access patient 
labs  participated  in  this  pilot  project.    Their 
experience in this field was on average 9 years 
(range  1-30  years).  All  accessed  the  EMR 
multiple  times  per  day  and  the  single  most 
accessed  tab  in  the  EMR  was  the  laboratory 
results  screen.    The  team  members  spent  an 
average of 18 minutes per patient gathering all 
laboratory data and an average of 4 minutes per 
patient on protein immunology labs.  Only 6 of 
the  10  indicated  that  they  were  either  familiar 
with or used the “trend” or “graph” feature of the 
EMR  to  view  serial  labs  with  numeric  results.  
All providers accessed the free text interpretation 
of the serum protein electrophoresis (SPEP) and 
immune  fixation  electrophoresis  (IFE)  as  that 
was the only way to learn about the presence of a 
myeloma protein, its quantitation and type.  Only 
7  of  the  10  indicated  that  they  accessed  and 
viewed a pdf file of the actual gels offered via a 
secure website (ARUP Enhanced Reports [14]). 
All  of  them  indicated  a  desire  to  see  multiple 
labs on a single report with the ability to view 
serial  changes  in  key  myeloma  biomarkers.  
Nearly all (8 of 10) expressed a willingness to 
collaborate with laboratory informatics teams to 
brainstorm  the  ideal  composite  report.    They 
were  also  willing  to  participate  in  a  validation 
study of the benefits of such a report for clinical 
care.    All  were  in  favor  of  providing  this 
composite report directly to patients.  Two key 
elements  were  highlighted  in  discussions  with 
the team: (1) the access to and downloading of 
disparate  protein  immunology  lab  data  along 
with the free text interpretation of SPEP and IFE 
was  challenging  and  time-consuming,  often 
requiring the simultaneous use of two computer 
screens and (2) A composite report with oft-used 
results  would  benefit  patient  care  and  improve 
the work flow. 
Data flow of laboratory orders and results: At 
the  University  of  Utah,  laboratory  orders  are 
currently initiated on paper, and then entered into 
the laboratory information system by clerks and 
laboratory staff.  Orders flow from the hospital 
information  system  (the  “Olympus”  system, 
powered  by  Cerner  Millenium  PowerChart; 
Cerner Corporation, Kansas City, MO) over an 
HL7 interface to ARUP’s laboratory information 
system (Cerner Millenium PathNet).  As shown 
in  Figure  1,     ARUP  maintains  a  separate 
information  technology  organization  from  the 
hospital,  including  staff  and  infrastructure,  and 
so  Olympus  runs  on  a  separate  instance  of 
Cerner  Millenium  from  the  LIMS.   Once 
laboratory  testing  is  complete,  test  results  are 
returned via HL7 interface to Olympus.  Results 
are  simultaneously  copied  to  both  the  hospital 
clinical data warehouse and ARUP’s own long 
term  repository.   Although  ARUP’s  LIMS 
remains the primary source of test results (data is 
retained  approximately  90  days  online,  and  in 
archived form for 7 years), order and result data 
are  replicated  in  a  SQL  Server  database 
(Microsoft,  Redmond,  WA)  called  the  ANSR 
system (ARUP’s Networked System Repository) 
in  order  to  support  a  variety  of  in-house 
developed  software  programs.   It  is  from  this 
40latter  database  that  ARUP’s  composite  and 
enhanced  laboratory  reports  are  generated.    A 
knowledge-  and  rules-based  inference  engine 
was developed that stores the logic to determine 
which  laboratory  data  to  present  in  enhanced 
form and on which patients, based on the data 
present in the ARUP data repository.  The rules 
are  simple  if-then-else  business  rules  that 
identify patients with immunology tests and their 
results.  When  specified  lab  data  enter  the  data 
repository, the engine triggers the generation of 
the actual composite report based on an end-user 
defined  information  layout,  including  numeric 
data, graphs, gels and text.  
 
  During  the  calendar  year  2007,  ARUP 
performed a total of 4699 protein immunology 
tests  on  1450  unique  patients  from  the 
University. As noted in the table, these tests are 
performed  multiple  times  on  myeloma  patients 
as  serial  results  are  important  for  the 
determination  of  progression  of  disease  and 
response to therapy.  Accessing and correlating 
even the last 3 results of tests that are reported in 
free text such as SPEP/IFE poses a challenge to 
providers  using  the  existing  reporting  format.  
Often, results of two or more different tests are 
used in the assessment of the patient’s disease 
status. 
 
Sample report: A sample composite report has 
been  created  (Figure  2)  that  captures  the  most 
often used biomarkers for myeloma patients. The 
design rationale for this report is based on the 
survey  results  and  semi-structured  interviews 
with providers who care for these patients. The 
free-text  interpretations  of  the  SPEP  and  IFE 
results are provided by the ARUP immunology 
lab  and  transmitted  to  the  University  EMR  as 
part  of  the  report.  These  results  provide  key 
information  regarding  the  presence,  type  and 
quantitation  of  a  myeloma  protein  in  the 
patient’s  blood.    Users  are  able  to  view  and 
download  the  report  as  a  pdf  file  via  a  secure 
website.  This  feature  has  been  successfully 
implemented  for  providing  other  enhanced 
reports.  ARUP  provides  secure  access  to  the 
website  with  a  computer  generated  log-in  and 
password available only to authorized viewers of 
the original report [14]. 
 
Table.  Protein  immunology  testing  at  ARUP  for 
University patients, January 1 – December 31, 2007. 
 
SPEP = serum protein electrophoresis 
IFE = immune fixation electrophoresis 
Q FLC = quantitative free light chains  
Ig = immunoglobulin 
 
Protein 
immunology 
test 
 
 
Total 
number 
of 
patients 
receiving 
this test 
Average 
number 
of orders 
per 
patient  
 
Max. 
number 
of orders 
per 
patient  
 
SPEP with 
reflex to IFE 
 
 
18  1  1 
SPEP alone 
 
741  1.99  34 
IFE, Ig A/G/M 
 
746  1.32  12 
IFE, Ig D/E 
 
19  1.05  2 
Urine Q FLC 
 
473  1.72  19 
Serum Q FLC 
 
150  5.15  40 
Serum Ig 
 
143  3.84  31 
 
Limitations 
  This is a pilot project that  was implemented 
with only one disease and one set of laboratory 
data. The unstructured free text interpretations of 
test  results  such  as  SPEP  and  IFE  were  not 
converted  to  “structured”  data.  The  existing 
interface  to  the  hospital  EMR  was  used  to 
provide the report in the EMR along with other 
protein  immunology  results.    At  this  time,  no 
information extraction is being performed on the 
free  text  sections  of  the  report  using  text 
processing  methods  that  have  been  applied  to 
pathology  and  radiology  reports  [15,  16]. 
Similarly,  there  are  no  analytics  performed  on 
the  composite  report  such  as  temporal 
abstraction for trends, patterns and inferences to 
the data [7, 17].  
  
Future Work 
  An  important  next  step  is  to  design  and 
perform  validation  studies  to  document  the 
utilization,  usability  and  benefit  of  these 
composite  reports  for  patient  care.    We  are 
planning a validation with the Myeloma team.  
 
  There exist opportunities for us to mine the 
composite report and extract information  using 
text processing [15, 16] and temporal abstraction 
methods  [7,  17].  Another  opportunity  is  to  be 
able to use a simple ontology that links patients, 
their  diseases  and  specific  batteries  of  tests, 
including serial ones (possibly with LOINC and 
41SNOMED as vocabularies).  These relationships 
would provide an advanced knowledge base for 
the inference engine that drives the generation of 
the composite report. 
   
Conclusions 
  There  are  several  key  steps  in  realizing  the 
goal  of  personalized  medicine  and  having  the 
ability to review integrated laboratory data in the 
electronic medical record that is both available at 
the point of care and be useful for clinical care.  
The  modern  clinical  laboratory  has  moved 
beyond reporting results that consisted of only of 
a numeric value with reference ranges and has to 
innovate  and  adapt  to  be  a  key  partner  in 
personalized medicine and translational research. 
 
  This novel descriptive project brings together 
multi-  and  inter-disciplinary  stakeholders  to 
understand  the  needs  of  the  users  and  provide 
comprehensive patient reports that contain both 
structured and unstructured data.  The intent is to 
decrease  the  information  gathering  burden  on 
providers and support clinical care.  This pilot 
laboratory  informatics  perspective  to 
personalized  medicine  seeks  to  inform  future 
collaborative  work  in  this  area.  The  data  flow 
and informatics solutions identified here will be 
directly  applicable  to  developing  complex 
reports  involving  molecular  genetics,  gene 
expression, micro-array and biomarker data. 
 
    The key issues identified by this project are 
(1)  Composite  reports  for  the  care  of  complex 
medical  patients  are  disease-  and  end-user 
specific  and  thus  calls  for  an  inter-disciplinary 
approach;  (2)  Unstructured  free  text 
interpretations  of  tests  are  important  elements 
and so further work needs to be done to provide 
“structure”  to  these  data  at  their  origin  in  the 
clinical laboratory; (3) Integrating  these reports 
with the EMR poses a challenge that needs to be 
addressed before clinical decision support can be 
offered  based  on  these  reports  and  (4)  There 
needs  to  be  a  mechanism  for  providing  these 
reports directly and securely to patients.  
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Figure 1.  Data flow and architecture of laboratory test orders and results between ARUP and the Hospital   
         
Data flow
(1) Laboratory orders are transmitted from the Hospital to ARUP 
(2) Laboratory results are transmitted from the ARUP LIMS to the Hospital Information System, Hospital Clinical Data Warehouse 
  and the ARUP System Repository 
(3) Pre-defined rules are applied to the data in the repository using a knowledge base and inference engine 
(4) On-demand and automatic generation of composite enhanced reports sent to the Hospital Information System 
 
Figure 2.  Sample composite report for multiple myeloma patients. The design rationale is based on end-
user preferences in terms of tests to be displayed, longitudinal data, free-text reports and images of gels 
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